Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8528ff66470c896b6da8ed059464e31f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_577821cf81fda3e1088e6ed08bcd136b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7155 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate |
2013-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_820fe6eeeb201c29b97a6ddfd240c039 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2405ff5807ef2bfbb8555f70e165029 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_011c78464531183cf1eb2abce9286305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60af19b5578565dc74ff8085f5ca68d0 |
publicationDate |
2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2894219-A1 |
titleOfInvention |
Novel interleukin-33 inhibitors |
abstract |
The present invention relates to novel inhibitors of IL-33. More specifically, it relates to a fusion protein of the soluble IL-33 receptor with the soluble IL-1RAcP as inhibitor of IL-33 activity. The invention relates further to the use of said inhibitor in treatment of IL-33 related diseases such as, but not limited to asthma, atopic dermatitis and psoriasis. |
priorityDate |
2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |